Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
ConclusionsALBI is a feasible marker for tumor recurrence. This easy-to-use ALBI grade-based nomogram may predict tumor recurrence for individual HCC patient undergoing surgical resection.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Bilirubin | Cancer & Oncology | Carcinoma | Chia | Hepatocellular Carcinoma | Liver | Liver Cancer | Surgery | Urology & Nephrology